SCHAUMBURG, Ill.--(BUSINESS WIRE)--Nov. 15, 2011--
Sparton Corporation (NYSE: SPA) announced that its Board has appointed
Mr. Charles R. Kummeth as an Independent Director, effective November
11, 2011. Mr. Kummeth was appointed after a search that was announced
earlier this year.
Mr. Kummeth is president of the Global Chromatography and Mass
Spectrometry Division of Thermo Fisher Scientific (NYSE:TMO). Previously
since 2009, Mr. Kummeth served as president of the Laboratory
Consumables Division of Thermo Fisher Scientific.
He has worked in the industrial, semiconductor, scientific, and
healthcare industries for 30 years, including 24 years at 3M. His
initial work was on data storage devices; an early project was helping
Apple with peripheral solutions for the first Macintosh computer. Later,
Mr. Kummeth managed 3M’s International Mergers and Acquisitions group,
and was vice president of the Electronics Materials and Medical Products
divisions. He spent three years in Europe as the head of 3M’s industrial
businesses and also served as managing director of the company’s
UK/Ireland subsidiary.
Mr. James R. Swartwout, Chairman of the Board said, “We are very pleased
with the addition of Chuck to Sparton’s Board of Directors. His
extensive skills in strategic planning, business development and
operational oversight in a large public company setting, as well as
having a marquee affiliation with the Medical and Industrial industries
will enable him to provide the Board with valuable insight as Sparton
continues to execute on its strategic growth plan.”
Mr. Kummeth commented, “I appreciate the opportunity to join the
Company’s Board of Directors and am looking forward to working closely
with our other Board members and the management team to further advance
the Company’s strategic development.”
Mr. Kummeth has a BS in Electrical Engineering, an MS in Software Design
and Engineering, and an MBA from the Carlson School of Business at the
University of Minnesota.
About Sparton Corporation
Sparton Corporation (NYSE:SPA), now in its 111th year, is a provider of
complex and sophisticated electromechanical devices with capabilities
that include concept development, industrial design, design and
manufacturing engineering, production, distribution, and field service.
The primary markets served are in the Medical Device, Defense & Security
Systems, and Electronic Manufacturing Services industries. Headquartered
in Schaumburg, IL, Sparton currently has five manufacturing locations
worldwide. Sparton's Web site may be accessed at http://www.sparton.com.
Safe Harbor and Fair Disclosure Statement
Safe Harbor statement under the Private Securities Litigation Reform Act
of 1995: To the extent any statements made in this release contain
information that is not historical, these statements are essentially
forward-looking and are subject to risks and uncertainties, including
the difficulty of predicting future results, the regulatory environment,
fluctuations in operating results and other risks detailed from time to
time in Sparton's filings with the Securities and Exchange Commission
(SEC). The matters discussed in this press release may also involve
risks and uncertainties concerning Sparton's services described in
Sparton's filings with the SEC. In particular, see the risk factors
described in Sparton's most recent Form 10K and Form 10Q. Sparton
assumes no obligation to update the forward-looking information
contained in this press release.
Source: Sparton Corporation
Analyst:
Sparton Corporation
Greg Slome, 847-762-5812
gslome@sparton.com
or
Media:
Sparton
Corporation
Mike Osborne, 847-762-5814
mosborne@sparton.com
or
Investors:
Institutional
Marketing Services
John Nesbett or Jennifer Belodeau, 203-972-9200
jnesbett@institutionalms.com
